Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
The current Eli Lilly(LLY) stock price is $985.42, with a market capitalization of 929.6B. The stock trades at a price-to-earnings (P/E) ratio of 42.92 and offers a dividend yield of 63.2%.
As of 2026-03-16, Eli Lilly(LLY) stock has fluctuated between $975.51 and $998.17. The current price stands at $985.42, placing the stock +1.0% above today's low and -1.3% off the high.
Eli Lilly(LLY) shares are trading with a volume of 1.18M, against a daily average of 2.45M.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.
LLY News
Eli Lilly Puts Obesity Field 'On Notice' With Best-Ever Weight Loss 12/10/2025 Eli Lilly is putting the "obesity field on notice again," an analyst said Thursd...
Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could infl...
Eli Lilly (LLY) announced topline results from the Phase 3 ADorable-1 trial evaluating the safety and efficacy of Ebglyss in pediatric patients with moderate-to...
Analyst ratings
80%
of 35 ratingsMore LLY News
Eli Lilly (LLY) is back in focus after outlining a US$3b, decade-long investment in China tied to its oral GLP-1 drug orforglipron, while separately pressing U....
In early March 2026, Eli Lilly announced a US$3.00 billion, decade-long expansion in China centered on local production and supply for its oral obesity pill orf...
Key Points Several pharmaceutical companies have recently posted encouraging clinical data for their weight-loss candidates. However, most of these won't be a...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. This early Eli Lilly study, titled “A Phase 1, Multicenter, Parallel-Design, S...
...
Eli Lilly (NYSE:LLY) announced a US$3b, decade-long plan to localize production and expand supply chain capacity for its oral obesity drug candidate, orforglipr...
Eli Lilly and Co (NYSE:LLY) on Thursday issued a public warning about potential safety risks linked to compounded tirzepatide products that are mixed with vitam...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.